NO158063C - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater.

Info

Publication number
NO158063C
NO158063C NO821882A NO821882A NO158063C NO 158063 C NO158063 C NO 158063C NO 821882 A NO821882 A NO 821882A NO 821882 A NO821882 A NO 821882A NO 158063 C NO158063 C NO 158063C
Authority
NO
Norway
Prior art keywords
pyrido
preparation
therapeutically active
analogy procedure
diazepine derivatives
Prior art date
Application number
NO821882A
Other languages
English (en)
Norwegian (no)
Other versions
NO821882L (no
NO158063B (no
Inventor
Guenther Schmidt
Wolfhard Engel
Wolfgang Eberlein
Guenter Trummlitz
Guenther Engelhardt
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO821882L publication Critical patent/NO821882L/no
Publication of NO158063B publication Critical patent/NO158063B/no
Publication of NO158063C publication Critical patent/NO158063C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO821882A 1981-06-06 1982-06-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater. NO158063C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813122670 DE3122670A1 (de) 1981-06-06 1981-06-06 "neue 1,4,9,10-tetrahydro-pyrazolo(4,3-e) pyrido(3,2-b)(1,4)diazepin-10-one, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von pharmazeutischen wirkstoffen"

Publications (3)

Publication Number Publication Date
NO821882L NO821882L (no) 1982-12-07
NO158063B NO158063B (no) 1988-03-28
NO158063C true NO158063C (no) 1988-07-06

Family

ID=6134176

Family Applications (1)

Application Number Title Priority Date Filing Date
NO821882A NO158063C (no) 1981-06-06 1982-06-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater.

Country Status (27)

Country Link
US (1) US4381303A (fr)
EP (1) EP0066774B1 (fr)
JP (1) JPS57212182A (fr)
KR (1) KR880001719B1 (fr)
AR (1) AR229124A1 (fr)
AT (1) ATE10744T1 (fr)
AU (1) AU552765B2 (fr)
CA (1) CA1167440A (fr)
CS (1) CS226743B2 (fr)
DD (1) DD202574A5 (fr)
DE (2) DE3122670A1 (fr)
DK (1) DK253382A (fr)
ES (1) ES512846A0 (fr)
FI (1) FI71560C (fr)
GB (1) GB2117755B (fr)
GR (1) GR76438B (fr)
HU (1) HU186067B (fr)
IE (1) IE53067B1 (fr)
IL (1) IL65977A (fr)
NO (1) NO158063C (fr)
NZ (1) NZ200859A (fr)
PH (1) PH17719A (fr)
PL (1) PL135845B1 (fr)
PT (1) PT75016B (fr)
SU (1) SU1103795A3 (fr)
YU (1) YU118282A (fr)
ZA (1) ZA823919B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3643666A1 (de) * 1986-12-20 1988-06-30 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4749788A (en) * 1987-04-13 1988-06-07 A. H. Robins Company, Incorporated Process for the preparation of aryl-pyrido(1,4) benzodiazepines
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
ES2063202T3 (es) * 1989-06-28 1995-01-01 Boehringer Ingelheim Pharma Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
CA2052946A1 (fr) * 1990-10-19 1992-04-20 Karl G. Grozinger Methode de preparation de 5,11-dihydro-6h-dipyrido¬3,2-b:2',3'-e|¬1,4|diazepines
ES2137113B1 (es) 1997-07-29 2000-09-16 Almirall Prodesfarma Sa Nuevos derivados de triazolo-piridazinas heterociclicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450694A (en) * 1966-02-23 1969-06-17 Abbott Lab Substituted benzoxazepines and benzothiazepines
DE2707269A1 (de) * 1977-02-19 1978-08-24 Hoechst Ag Heterocyclische stickstoffverbindungen und verfahren zu ihrer herstellung
NZ194529A (en) * 1979-08-03 1983-05-10 Byk Gulden Lomberg Chem Fab 9,10-dihydro-1h, 4h-pyrazolo (4,3-b)(1,5)benzodiazepin-10-ones

Also Published As

Publication number Publication date
DD202574A5 (de) 1983-09-21
US4381303A (en) 1983-04-26
CS226743B2 (en) 1984-04-16
DK253382A (da) 1982-12-07
JPS57212182A (en) 1982-12-27
SU1103795A3 (ru) 1984-07-15
ES8304571A1 (es) 1983-03-01
ATE10744T1 (de) 1984-12-15
ES512846A0 (es) 1983-03-01
CA1167440A (fr) 1984-05-15
EP0066774A1 (fr) 1982-12-15
PH17719A (en) 1984-11-21
PL135845B1 (en) 1985-12-31
EP0066774B1 (fr) 1984-12-12
DE3261530D1 (en) 1985-01-24
PT75016A (de) 1982-07-01
IE821350L (en) 1982-12-06
ZA823919B (en) 1984-02-29
NO821882L (no) 1982-12-07
AU8460582A (en) 1982-12-16
KR840000543A (ko) 1984-02-25
NZ200859A (en) 1985-08-16
KR880001719B1 (ko) 1988-09-08
YU118282A (en) 1986-04-30
PL236742A1 (en) 1984-03-26
GB2117755A (en) 1983-10-19
FI71560C (fi) 1987-01-19
GR76438B (fr) 1984-08-10
IL65977A0 (en) 1982-09-30
FI821992A0 (fi) 1982-06-04
IE53067B1 (en) 1988-05-25
AR229124A1 (es) 1983-06-15
FI71560B (fi) 1986-10-10
AU552765B2 (en) 1986-06-19
DE3122670A1 (de) 1982-12-23
HU186067B (en) 1985-05-28
NO158063B (no) 1988-03-28
IL65977A (en) 1984-12-31
PT75016B (de) 1985-05-17
GB2117755B (en) 1985-01-30

Similar Documents

Publication Publication Date Title
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO161372C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive guaninderivater.
NO159531C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO159446C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO156864C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO821904L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO156865C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO154052C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.
NO155539C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme isokinolinderivater.